Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Kevin Kotler’s Broadfin Capital Joins HealthCor in Idera

Broadfin Capital, Idera Pharmaceuticals: Just now, Kevin Kotler’s Broadfin Capital disclosed adding Idera Pharmaceuticals Inc (NASDAQ:IDRA) to its equity portfolio in a filing with the Securities and Exchange Commission. The fund, with an inclination towards healthcare stocks, reported purchasing over 4.5 million shares of Idera, which gives Kotler an almost 7.7% position in the company. At the current price of Idera Pharmaceuticals’ stock, the value of the position acquired by Broadfin amounts to some $13.2 million. HealthCor Management reported a 5.6% stake earlier this morning.

Idera Pharmaceuticals Inc (NASDAQ:IDRA)

Disclosure: none